AN2 Therapeutics, Inc. (ANTX) Misses Q1 EPS by 10c

AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q1 EPS of ($0.35), $0.10 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.

You May Also Be Interested In

• Samsara Inc (IOT) call put ratio 4.5 calls to 1 put with a focus on September 4 weekly calls into quarter results
• Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
• Google DeepMind launches WeatherNext 3 AI weather model